SC Filed 2024-10-15 Event — SEC 0001193125-24-237613 →

Kalayoglu Murat → Cartesian Therapeutics, Inc. RNAC

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +63.4%

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (11.7 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 0 sales · 2 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 11.73

1,875,103 shares short · +1.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $244K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-02	Hoge Elizabeth	10%+ owner	Option exercise	758,001	—	—
2026-04-02	Kalayoglu Murat	10%+ owner	Option exercise	758,001	—	—

Other 13D/G Filings on Cartesian Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-02	SCHEDULE 13D/A	Kalayoglu Murat	19.90%	5,833,971	view →
2025-01-15	SCHEDULE	SPRINGER TIMOTHY A	36.90%	9,555,394	view →
2024-07-05	SC	SPRINGER TIMOTHY A	—	—	view →
2024-04-12	SC	SPRINGER TIMOTHY A	—	—	view →
2021-12-27	SC	SPRINGER TIMOTHY A	—	—	view →
2021-05-27	SC	SPRINGER TIMOTHY A	—	—	view →
2020-10-23	SC	SPRINGER TIMOTHY A	—	—	view →
2020-10-15	SC	SPRINGER TIMOTHY A	—	—	view →
2020-02-05	SC	ORBIMED ADVISORS LLC	—	—	view →
2020-01-02	SC	SPRINGER TIMOTHY A	—	—	view →
2019-12-17	SC	SPRINGER TIMOTHY A	—	—	view →
2019-11-13	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-02-04	SC	Polaris Venture Partners V, L.P.	—	—	view →
2018-05-03	SC	Polaris Venture Partners V, L.P.	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Kalayoglu Murat

Filed	Form	Issuer	Stake	Shares
2026-04-02	SCHEDULE 13D/A	Cartesian Therapeutics, Inc. RNAC	19.90%	5,833,971	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →